| Biomarkers predicting outcome in patients with advanced renal cell carcinoma ... - UroToday |
|
|
UroToday903 patients with advanced renal cell carcinoma (RCC) were randomized to sorafenib 400 mg bid or placebo. ELISAs were performed on samples collected at ... read more |